SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

14 Aug 2023 Evaluate
The Revenue for the quarter ended  June 2023 of Rs. 115.44 millions grew by 19.42 % from Rs. 96.67 millions.The Net Loss for the quarter ended June 2023 is Rs. -24.59 millions as compared to Net Loss of Rs. -22.73 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 further decreased to -15.95% as compared to -13.88% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 115.44 96.67 19.42 115.44 96.67 19.42 425.47 523.76 -18.77
Other Income 1.90 1.34 41.79 1.90 1.34 41.79 11.37 8.48 34.08
PBIDT -15.95 -13.88 14.91 -15.95 -13.88 14.91 -29.97 38.97 -176.91
Interest 3.48 3.69 -5.69 3.48 3.69 -5.69 13.81 16.75 -17.55
PBDT -19.43 -17.57 10.59 -19.43 -17.57 10.59 -43.78 22.22 -297.03
Depreciation 6.69 4.79 39.67 6.69 4.79 39.67 23.99 19.07 25.80
PBT -26.12 -22.36 16.82 -26.12 -22.36 16.82 -67.77 3.15 -2251.43
TAX -1.53 0.37 -513.51 -1.53 0.37 -513.51 -4.15 1.41 -394.33
Deferred Tax -1.53 0.37 -513.51 -1.53 0.37 -513.51 -4.30 1.08 -498.15
PAT -24.59 -22.73 8.18 -24.59 -22.73 8.18 -63.62 1.74 -3756.32
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 49.17 19.99
PBIDTM(%) -13.82 -14.36 -3.77 -13.82 -14.36 -3.77 -7.04 7.44 -194.67

Makers Laboratories Share Price

155.80 -4.35 (-2.72%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×